Vestcor Inc’s Ibere Pharmaceuticals Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share IBER.WS Stock Holding History

Vestcor Inc’s Portfolio IBER.WS Stock Details IBER.WS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-200,000	Closed	-$2K	–	1353
2022 Q4	$2K	Hold	200,000	–	–	﹤0.01%	1239
2022 Q3	$20K	Hold	200,000	–	–	﹤0.01%	1200
2022 Q2	$16K	Hold	200,000	–	–	﹤0.01%	1192
2022 Q1	$40K	Hold	200,000	–	–	﹤0.01%	1202
2021 Q4	$108K	Hold	200,000	–	–	﹤0.01%	1017
2021 Q3	$120K	Hold	200,000	–	–	﹤0.01%	972
2021 Q2	$152K	Buy	+200,000	New	+$121K	0.01%	961

Other funds holding IBER.WS

LCM

Lynwood Capital Management Toronto, Ontario, Canada $16.9M AUM 19.31% 1-Year Est. Return

Vestcor Inc's IBER.WS Position: Q1 2023 in Review

Vestcor Inc sold out of Ibere Pharmaceuticals Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share (IBER.WS) in Q1 2023, closing a stake of 200,000 shares — an estimated $2K sold.

Vestcor Inc first reported a position in IBER.WS in Q2 2021 and held it in 7 quarters. The position peaked at $152K in Q2 2021. 1 fund tracked by Wall St. Rank holds IBER.WS as of Q1 2023.

Vestcor Inc reported no remaining Ibere Pharmaceuticals Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share position as of Q1 2023 after selling out during the quarter.
Vestcor Inc sold 200,000 Ibere Pharmaceuticals Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share shares in Q1 2023, an estimated $2K.
Vestcor Inc first reported a position in Ibere Pharmaceuticals Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share in Q2 2021 and held it in 7 quarters.
Vestcor Inc's Ibere Pharmaceuticals Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share position peaked at $152K in Q2 2021.
1 fund tracked by Wall St. Rank held Ibere Pharmaceuticals Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share as of Q1 2023.

Based on Vestcor Inc's 13F filing for Q1 2023, filed 15 May 2023.